OrbiMed Advisors LLC

https://www.orbimed.com

OrbiMed is a leading healthcare investment firm, with approximately $19 billion in assets under management. OrbiMed invests globally across the healthcare industry through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya and other key global markets. *

	Start	1989-01-01 established
	Group	OrbiMed (Group)
	Industry	private equity
	Industry 2	LIFE SCIENCES
	Person	Gordon, Carl L. (OrbiMed Advisors 201509 Partner)

	Region	New York, NY
	Country	United States (USA)
	Street	601 Lexington Avenue 54th Floor
	City	10022 New York, NY
	Tel	+1-212-739-6400
		Address record changed: 2021-12-06

Basic data	Employees	D: 101 to 500 (2023-10-24)
	Currency	USD
	Annual sales	17,000,000,000 (assets under management (2023) 2023-10-24)

		* Document for »About Section«: Nerre Therapeutics Ltd.. (7/7/21). "Press Release: Nerre Therapeutics Raises £20 Million in a Series B2 Financing Round". Stevenage.

		Record changed: 2024-04-07

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

More documents for OrbiMed (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)